About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Atlanta | 412 Studies

Clinical Trials Breast CancerAtlanta

Breast Cancer Clinical Trials in Atlanta

Find 412 clinical trials for breast cancer near Atlanta, Georgia. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Atlanta

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 412 trials

TerminatedA Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast CancerThe open-label Phase Ib portion of this study will evaluate the safety and pharmacokinetics of ipatasertib in combination with palbociclib and fulvestrant to identify a dose of…NCT04060862·Atlanta, Georgia and 19 others CompletedA Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast CancerThis trial studies how well the drug tucatinib works when given with trastuzumab deruxtecan (T-DXd).NCT04539938·Birmingham, Alabama and 139 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingDCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentThe goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an early stage of breast…NCT06075953·Berkeley, California and 29 others

CompletedChemotherapy Monitoring With Breast Computed Tomography (CT)The purpose of this study is to determine if dedicated breast computed tomography can be used successfully to monitor tumor response in breast cancer patients undergoing…NCT00808041·Atlanta, Georgia

CompletedS0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00015938·Mobile, Alabama and 98 others

CompletedAn Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).NCT01615068·Birmingham, Alabama and 141 others

UnknownThe Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid TumorsA Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid TumorsNCT04768868·Atlanta, Georgia and 15 others

Active not recruitingA Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast cancer.NCT05132582·Phoenix, Arizona and 306 others

CompletedDS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unresectable and/or metastatic breast…NCT03529110·Los Angeles, California and 163 others

RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsThe goal of the Monotherapy Dose Escalation phase (Part 1) of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to…NCT06586957·Little Rock, Arkansas and 20 others

CompletedE7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast CancerThe purpose of this study is to compare Overall Survival (OS), Progression Free Survival (PFS), objective tumor response rate, duration of response, and safety in patients treated…NCT00388726·Birmingham, Alabama and 136 others

CompletedA Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, to assess PK and…NCT03752398·San Diego, California and 17 others

Active not recruitingDigital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast CancerThis randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer.NCT03233191·Birmingham, Alabama and 148 others

CompletedA Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid TumorsPicoplatin is a new platinum-based chemotherapy drug that has been studied in a variety of cancers.NCT00465725·Atlanta, Georgia and 2 others

CompletedEvaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationThis is an open label, randomized, multicenter study evaluating the activity of lasofoxifene relative to fulvestrant for the treatment of pre- and postmenopausal women with…NCT03781063·Phoenix, Arizona and 50 others

CompletedFluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerThis phase I trial studies how well fluciclovine positron emission tomography (PET)/computed tomography (CT) and PSMA PET/CT work in helping doctors understand and classify…NCT04750473·Atlanta, Georgia

CompletedAdjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast CancerThis was an open label, multi-center protocol for U.S. patients enrolled in the study of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone…NCT03078751·Tucson, Arizona and 32 others

CompletedA Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast CancerThis randomized, open-label, two-arm, multi-center, Phase II study will evaluate the efficacy and safety of pertuzumab in combination with trastuzumab plus an aromatase inhibitor…NCT01491737·Birmingham, Alabama and 81 others

TerminatedLetrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryRATIONALE: Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes.NCT00651976·Atlanta, Georgia and 4 others

CompletedEvaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerThe goal of this study is to compare two different types of breast surgery. In the first type, the doctor removes only the tumor.NCT01271738·Atlanta, Georgia

PreviousPage 11 of 21Next

Other Conditions in Atlanta

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma